KLRB1
Killer cell lectin-like receptor subfamily B member 1
Also known as: CD161, CLEC5B, hNKR-P1A, KLRB1_HUMAN, NKR, NKR-P1, NKR-P1A
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q12918
- Gene
- KLRB1
- Ensembl
- ENSG00000111796
- Chromosome
- 12
- Canonical length
- 225 aa
- Protein class
- CD markers, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Natural killer (NK) cells are lymphocytes that mediate cytotoxicity and secrete cytokines after immune stimulation. Several genes of the C-type lectin superfamily, including the rodent NKRP1 family of glycoproteins, are expressed by NK cells and may be involved in the regulation of NK cell function. The KLRB1 protein contains an extracellular domain with several motifs characteristic of C-type lectins, a transmembrane domain, and a cytoplasmic domain. The KLRB1 protein is classified as a type II membrane protein because it has an external C terminus. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
225 residues, UniProt reviewed canonical sequence.
>Q12918|KLRB1
1 MDQQAIYAEL NLPTDSGPES SSPSSLPRDV CQGSPWHQFA LKLSCAGIIL LVLVVTGLSV
61 SVTSLIQKSS IEKCSVDIQQ SRNKTTERPG LLNCPIYWQQ LREKCLLFSH TVNPWNNSLA
121 DCSTKESSLL LIRDKDELIH TQNLIRDKAI LFWIGLNFSL SEKNWKWING SFLNSNDLEI
181 RGDAKENSCI SISQTSVYSE YCSTEIRWIC QKELTPVRNK VYPDSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KLRB1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 45 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 45 nTPM
- tonsil: 34 nTPM
- spleen: 27 nTPM
- small intestine: 19 nTPM
- lymph node: 19 nTPM
- appendix: 17 nTPM
Single-cell type
- innate lymphoid cells: 955 nCPM
- nk-cells: 951 nCPM
- t-cells: 644 nCPM
- hematopoietic stem cells: 25 nCPM
- pdcs: 22 nCPM
- kupffer cells: 18 nCPM
Immune cell
- MAIT T-cell: 2,181 nTPM
- NK-cell: 758 nTPM
- gdT-cell: 521 nTPM
- memory CD8 T-cell: 346 nTPM
- memory CD4 T-cell: 308 nTPM
- total PBMC: 285 nTPM
Brain region
- cerebral cortex: 1.7 nTPM
- white matter: 1.7 nTPM
- basal ganglia: 1.6 nTPM
- hypothalamus: 1.5 nTPM
- amygdala: 1.4 nTPM
- medulla oblongata: 1.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.44
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.13
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- C-type lectin-like
- C-type lectin-like/link domain superfamily
- C-type lectin fold
- Natural killer cell receptor-like, C-type lectin-like domain
- Lectin C-type domain
- Killer cell lectin-like receptor subfamily B
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KLRB1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KLRB1 as an antibody target. Whether an autoantibody or antibody against KLRB1 could matter depends on whether native KLRB1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KLRB1 is annotated at the cell surface, where native KLRB1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label KLRB1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...